Moreover, the capacity of PTX to modulate the NLRP3 inflammasome, in the TNBC context, has been investigated, and the obtained data highlighted that NLRP3 pre-treatment facilitated the effects of PTX on tumor cells, therefore reducing the cancer-associated inflammation [28]. This evidence concerns the gene NLRP3 and neoplasm.